A protective anti-peptide antibody against the immunodominant site of the A24 Cruzeiro strain of foot-and-mouth disease virus and its reactivity with other subtype viruses containing the same minimum binding sequence

Journal of General Virology

Volumn 77, Issue 5, 1996, Pages 1011-1018

  Barnett, P V ^a   Pullen, L ^a   Staple, R F ^a   Lee, L J ^a   Butcher, R ^a   Parkinson, D ^a   Doel, T R ^a,b  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Rhône Mérieux Limited   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; MONOCLONAL ANTIBODY; SYNTHETIC PEPTIDE; VIRUS ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOT AND MOUTH DISEASE VIRUS; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; VIRUS INFECTIVITY; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; APHTHOVIRUS; CAPSID; CAPSID PROTEINS; CELL LINE; CRICETINAE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; VACCINES, SYNTHETIC;

EID: 0029947467     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-77-5-1011     Document Type: Article

References (34)

1. ACHARYA, R., FRY, E., STUART, D., FOX, G., ROWLANDS, D. & BROWN, F. (1989). The three-dimensional structure of foot-and-mouth disease virus at 2-9 Å resolution. Nature 337, 709-716.
2. AL MOUDALLAL, Z., BRIAND, J. P. & VAN REGENMORTEL, M. H. V. (1982). Monoclonal antibodies as probes of the antigenic structure of tobacco mosaic virus. EMBO Journal 1, 1005-1010.
3. BARNETT, P. V., ROWLANDS, D. J. & PARRY, N. R. (1993). Characterization of monoclonal antibodies raised against a synthetic peptide capable of inducing a neutralizing response to human rhinovirus type 2. Journal of General Virology 74, 1295-1302.
4. BARNETT, P. V., ROWLANDS, D. J., CAMPBELL, R. O. & PARRY, N. R. (1995). Monoclonal antibodies to a peptide of human rhinovirus type 2 with different specificities recognize the same minimum sequence. Journal of General Virology 76, 1255-1261.
5. BECK, E. & STROHMAIER, K. (1987). Subtyping of European foot-and-mouth disease virus strains by nucleotide sequence determination. Journal of Virology 61, 1621-1629.
6. BITTLE, J. L., HOUGHTEN, R. A., ALEXANDER, H., SHINNICK, T. M., SUTCLIFFE, J. G., LERNER, R. A., ROWLANDS, D. J. & BROWN, F. (1982). Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence. Nature 298, 30-33.
7. BOLWELL, C., CLARKE, B. E., PARRY, N. R., OULDRIDGE, E. J., BROWN, F. & ROWLANDS, D. J. (1989). Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. Journal of General Virology 70, 59-68.
8. BOOTH, J. C., RWEYEMAMU, M. M. & PAY, T. W. F. (1978). Dose response relationships in a microneutralization test for foot-and-mouth disease viruses. Journal of Hygiene 80, 31-42.
9. BRIOEN, P., DEKEGEL, D. & BOEYÉ, A (1983). Neutralization of poliovirus by antibody-mediated polymerization. Virology 127, 463-468.
10. BROWN, F. & CARTWRIGHT, B. (1963). Purification of radioactive foot-and-mouth disease virus. Nature 199, 1168-1170.
11. BUTCHER, R. N., OBI, T U. & MCCULLOUGH, K. C. (1991). Rapid isolation of monoclonal hybridoma cultures by a 'fusion-cloning' method: the requirement for aminopterin. Biologicals 19, 171-175.
12. COOPER, H. M., JEMMERSON, R., HUNT, D. F., GRIFFIN, P. R., YATES, J. R., SHABANOWITZ, J., ZHU, N. & PATERSON, Y. (1987). Site-directed chemical modification of horse cytochrome C results in changes in antigenicity due to local and long-range conformational perturbations Journal of Biological Chemistry 262, 11592-11597.
13. DIMARCHI, R., BROOKE, G., GALE, C., CRACKNELL, V., DOEL, T. & MOWAT, N. (1986). Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232, 639-641.
14. DOEL, T. R., GALE, C., Do AMARAL, M. C. F., MULCAHY, G. & DIMARCHI, R. (1990). Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. Journal of Virology 64, 2260-2264.
15. DOEL, T. R., DOEL, C. M. F. A., STAPLE, R. F. & DIMARCHI, R. (1992). Cross-reactive and serotype-specific antibodies against foot-and-mouth disease virus generated by different regions of the same synthetic peptide. Journal of Virology 66, 2187-2194.
16. FERGUSON, M., REED, S. E. & MINOR, P. D. (1986). Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides. Journal of General Virology 67, 2527-2531.
17. FOX, G., PARRY, N. R., BARNETT, P. V., MCGINN, B., ROWLANDS, D. J. & BROWN, F. (1989). The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). Journal of General Virology 70, 625-637.
18. HASTINGS. G. Z., SPELLER, S. A. & FRANCIS, M. J. (1990). Neutralizing antibodies to human rhinovirus produced in laboratory animals and humans that recognize a linear sequence from VP2. Journal of General Virology 71, 3055-3059.
19. IBRAHIMI, I. M., PRAGER, E. M., WHITE, T. J. & WILSON, A. C. (1979). Amino acid sequence of California quail lysozyme: effect of evolutionary substitutions on the antigenic structure of lysozyme. Biochemistry 13, 2736-2744.
20. KARBER, G. (1931). Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Archiv für experimentelle Pathologie und Pharmakologie 162, 480-483.
21. MCCULLOUGH, K. C., CROWTHER, J. R. & BUTCHER, R. N. (1985). Alteration in antibody reactivity with foot-and-mouth disease virus (FMDV) 146S antigen before and after binding to a solid phase or complexing with specific antibody. Journal of Immunological Methods 82, 91-100.
22. MASON, P. W., REIDER, E. & BAXT, B. (1994). RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway. Proceedings of the National Academy of Sciences, USA 91, 1932-1936.
23. MERRIFIELD, R. B. (1963). Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. Journal of the American Chemical Society 85, 2149-2154.
24. MOSSER, A. G., LEIPPE, D. M. & RUECKERT, R. R. (1989). Neutralization of picornaviruses: support for the pentamer bridging hypothesis. In Molecular Aspects of Picornavirus Infection and Detection, pp. 156-158. Edited by B. L. Semler & E. Ehrenfeld. Washington, DC : American Society for Microbiology.
25. MULCAHY, G., PULLEN, L. A., GALE, C., DIMARCHI, R. D. & DOEL, T. R. (1991). Mouse protection test as a predictor of the protective capacity of synthetic foot-and-mouth disease vaccines. Vaccine 9, 19-24.
26. PARRY, N. R., OULDRIDGE, E. J., BARNETT, P. V., CLARKE, B. E., FRANCIS, M. J., FOX, J. D., ROWLANDS, D. J. & BROWN, F. (1989). Serological prospects for peptide vaccines against foot-and-mouth disease virus Journal of General Virology 70, 2919-2930.
27. PARRY, N., FOX, G., ROWLANDS, D , BROWN, F., FRY, E., ACHARYA, R., LOGAN, D. & STUART, D. (1990). Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature 347, 569-572.
28. PFAFF, E., MUSSGAY, M., BOHM, H. O., SCHULZ, G. E. & SCHALLER, H. (1982). Antibodies against a preselected peptide recognise and neutralize foot-and-mouth disease virus. EMBO Journal 1, 869-874.
29. RWEYEMAMU, M. M. & HINGLEY, P. J. (1984). Foot-and-mouth disease virus strain differentiation: analysis of the serological data. Journal of Biological Standardization 12, 323-337.
30. STROHMAIER, K., FRANZE, R. & ADAM, K. H. (1982). Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59, 295-306.
31. THOMAS, A. A. M., BRIOEN, P. & BOEYÉ, A. (1985). A monoclonal antibody that neutralizes poliovirus by cross-linking virions Journal of Virology 54, 7-13.
32. TORMO, J., BLAAS, D., PARRY, N. R. ROWLANDS, D., STUART, D. & FITA, I. (1994). Crystal structure of a human rhinovirus neutralizing antibody complexed with a peptide derived from viral capsid protein VP2. EMBO Journal 13, 2247-2256.
33. WEDDELL, G. N., YANSURA, D. G., DOWBENKO, D. J., HOATLIN, M. E., GRUBMAN, M. J., MOORE, D. M. & KLEID, D. G. (1985). Sequence variation in the gene for the immunogenic capsid protein VP1 of foot-and-mouth disease virus type A. Proceedings of the National Academy of Sciences, USA 82, 2618-2622.
34. WETZ, K. (1993). Attachment of neutralizing antibodies stabilizes the capsid of poliovirus against uncoating. Virology 192, 465-472.